Nemetschek stock gains JPMorgan Overweight upgrade after Q3
Published on 11/11/2026 at 11:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst Upgrade Meets Mixed Growth
- JPMorgan raised Nemetschek to Overweight after the third-quarter update.
- Recurring revenue and the HCSS acquisition support growth, while segment trends and acquisition effects pressure the quality of reported earnings.
- Management retained its 2026 targets for organic growth and EBITDA margin.
JPMorgan upgraded Nemetschek to Overweight on Monday, November 9, after the software group released its third-quarter results on November 5. The move adds a more constructive broker view to an investor debate focused on recurring revenue, HCSS integration and the quality of reported margins, according to Ad Hoc News.
Broker View Shifts After Results
The upgrade follows a quarter in which Nemetschek reported strong headline growth but a more uneven underlying picture. Group revenue rose 26.6 percent year over year to EUR 371.1 million, including HCSS from July 1. Organic revenue growth reached 13.7 percent on a reported basis and 12.5 percent at constant currency.
Recurring revenue remains a central part of the bullish case. Annual recurring revenue increased 35.8 percent to EUR 1,462.2 million, while subscription and software-as-a-service revenue rose 52.4 percent to EUR 321.9 million. The figures point to continued expansion of the group's recurring model, although investors still have to assess how quickly the HCSS contribution converts into sustainable earnings.
HCSS Changes The Growth Mix
The acquisition lifted reported growth and helped the Build division. Build revenue rose 56.6 percent to EUR 190.8 million, supported by HCSS and Bluebeam Max. Design revenue grew 7.2 percent, while Media revenue declined 2.7 percent as customer spending remained subdued and purchasing decisions took longer.
Acquisition-related effects make the earnings picture less straightforward. Reported third-quarter EBITDA increased 21.8 percent to EUR 115.9 million, producing a 31.2 percent margin. The organic EBITDA margin was 34.8 percent. Reported earnings per share fell to EUR 0.40, while adjusted earnings per share rose 20.0 percent to EUR 0.66.
Nemetschek expects HCSS to add 600 basis points to currency-adjusted group revenue growth. Purchase-price-allocation effects, integration costs and share-based compensation are expected to weigh on the reported margin. This leaves execution and margin normalization as key tests for the upgraded investment case.
Targets Remain Unchanged
Management retained its 2026 target for 14 to 15 percent organic currency-adjusted revenue growth and an EBITDA margin of 32 to 33 percent. The unchanged group targets give the broker upgrade a firm operating reference, but they also leave the company with a demanding delivery requirement as segment performance diverges.
Nemetschek stock traded at EUR 63.33 on Lang & Schwarz at 11:47 CET on Wednesday, November 11, 2026, 1.51 percent below the Xetra close of Tuesday, November 10, at EUR 64.30. The quote places the shares below the prior Xetra session while the market weighs the upgraded broker view against integration and margin risks.
Nemetschek stock at a glance
- Company: Nemetschek SE
- ISIN: DE0006452907
- Stock: NEM.DE
- Latest quote: EUR 63.33 on Lang & Schwarz, Wednesday, November 11, 2026, 11:47 CET
- Daily comparison: 1.51 percent below the Xetra close of Tuesday, November 10, 2026, at EUR 64.30
- Indices: MDAX, TecDAX
The broader German market remains relevant for context; see current market reports for the DAX environment.
Further attention will center on HCSS execution, recurring-revenue growth and the path from organic operating performance to reported margins. More news and analyses on Nemetschek stock cover these developments.
